Durgical
EN
Open the app

Chronic progressive external ophthalmoplegia

A mitochondrial disease causing slow, symmetric droopy lids and limited eye movements, usually without double vision. Kearns-Sayre adds heart block.

Updated

What it is

Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial myopathy with slowly worsening, usually symmetric, bilateral ptosis and ophthalmoplegia, so double vision is uncommon. Kearns-Sayre syndrome is the severe form, starting before age 20 with pigmentary retinopathy and cardiac conduction block.

Who gets it

Rare; the most common ocular presentation of mitochondrial disease. Usually begins in young adulthood; Kearns-Sayre starts before 20 years.

Causes

  • Single large deletion of mitochondrial DNA (sporadic), as in Kearns-Sayre syndrome
  • Point mutations of mtDNA (for example m.3243A>G, also seen in MELAS)
  • Nuclear genes affecting mtDNA maintenance: POLG, TWNK, SLC25A4, RRM2B (multiple deletions, autosomal dominant or recessive)

Risk factors

  • Family history of mitochondrial disease
  • Maternal inheritance for point mutations

Pathophysiology

Defective oxidative phosphorylation affects tissues with high energy demand. The extraocular muscles and levator, which have very high mitochondrial content, weaken first. Muscle biopsy shows ragged-red fibres and cytochrome c oxidase-negative fibres.

Classification

  • Isolated CPEO
  • CPEO plus: with proximal myopathy, neuropathy, ataxia, deafness or other features
  • Kearns-Sayre syndrome: onset before 20, pigmentary retinopathy and one of heart block, cerebellar ataxia or high CSF protein

Symptoms and signs

  • Slowly progressive drooping of both upper lids
  • Limited eye movements in all directions with little or no double vision
  • Weak eye closure (orbicularis weakness)
  • Exercise intolerance or limb weakness
  • Hearing loss, short stature or poor night vision in syndromic forms

Diagnosis

Clinical
Bilateral symmetric ptosis and ophthalmoplegia with slow progression, normal pupils and no fatigability; fundus check for salt-and-pepper retinopathy.
Tests
Electrocardiogram and Holter for conduction block, creatine kinase, lactate, muscle biopsy (ragged-red fibres), mtDNA analysis in muscle and nuclear gene panels; antibody testing to exclude myasthenia.
Imaging
MRI of the orbits may show thin extraocular muscles; brain MRI in syndromic forms.

Differential diagnosis

Slow bilateral ptosis and ophthalmoplegia: CPEO vs its look-alikes

FeatureCPEOMyasthenia gravisOculopharyngeal muscular dystrophyThyroid eye disease
CourseSlow over years, steadyFluctuating, worse later in the daySlow, usually starting in later adulthoodActive phase, then stable
Double visionRareCommonUncommonCommon
SymmetrySymmetricOften asymmetricSymmetricOften asymmetric
LidsPtosis, weak closureFatigable ptosisPtosisLid retraction, not ptosis
SwallowingUsually normalCan be fatigableDysphagia prominentNormal
Key testECG, muscle biopsy (ragged-red fibres), mtDNA analysisIce-pack test, antibodiesGenetic test (PABPN1)Thyroid tests, orbital imaging (enlarged muscles)

Goal of treatment

Protect the cornea, improve the lid position and screen for heart and systemic complications; there is no cure.

Treatment

Surgical
Conservative ptosis repair (frontalis sling or limited levator surgery) to avoid corneal exposure.
Procedure
Pacemaker for conduction block in Kearns-Sayre syndrome.
Conservative
Lubricants, lid crutches on glasses and prisms for any deviation.
Follow-up
Regular electrocardiograms, hearing, endocrine and retinal review; genetic counselling.

Complications

Common traps

  • Bilateral ptosis with ophthalmoplegia is myasthenia until proved otherwise: myasthenia fluctuates, fatigues and causes diplopia, while CPEO is slow, steady, symmetric and seldom causes double vision; pupils are normal in both
  • CPEO is only an eye problem: Kearns-Sayre and other forms can cause complete heart block and sudden death, so every patient needs ECG screening and follow-up
  • Ptosis surgery should lift the lids fully: weak eye closure, limited upgaze and a poor Bell phenomenon make full correction risky, so repair is deliberately conservative to avoid exposure keratopathy
  • Mitochondrial disease is always maternally inherited: single large mtDNA deletions are usually sporadic and nuclear genes such as POLG cause autosomal forms; only mtDNA point mutations pass down the maternal line
  • Limited movement in all directions means a supranuclear palsy: in CPEO the muscles themselves are weak, so doll's-eye movements do not overcome the limit, whereas in progressive supranuclear palsy they do

Prognosis

Isolated CPEO progresses slowly with normal life expectancy; Kearns-Sayre syndrome carries cardiac and neurological risks that shorten survival.

Test yourself

Think of the answer, then tap the question to see it.

A 30-year-old has had slowly worsening ptosis and limited eye movements in all directions for years, but no double vision. Why no diplopia?

Both eyes weaken slowly and equally, so they stay roughly aligned and the brain adapts; diplopia needs misalignment.

A 16-year-old with ptosis, ophthalmoplegia and salt-and-pepper retinopathy faints. What is the likely cause and the urgent test?

Kearns-Sayre syndrome with complete heart block: urgent ECG and cardiac monitoring; a pacemaker may be needed.

Why is ptosis surgery in CPEO kept conservative?

Weak orbicularis, limited upgaze and a poor Bell phenomenon leave the cornea unprotected if the lids are lifted fully, risking exposure keratopathy.

Which bedside manoeuvre separates CPEO from progressive supranuclear palsy?

Doll's-eye (oculocephalic) movements: they overcome the limit in progressive supranuclear palsy, a supranuclear problem, but not in CPEO, where the muscles are weak.

What does a muscle biopsy show in CPEO, and why?

Ragged-red and cytochrome c oxidase-negative fibres: mitochondria proliferate under the sarcolemma to compensate for defective oxidative phosphorylation.

Add to my cards (5)

In neurology

Connections

Educational information, not medical advice. For any symptom, see a health professional.

Sources: Chronic Progressive External Ophthalmoplegia (CPEO) (EyeWiki (American Academy of Ophthalmology), 2025); Kearns-Sayre Syndrome (StatPearls Publishing (NCBI Bookshelf), 2023); Progressive external ophthalmoplegia: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026).

← All conditions

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.